FIELD: medicine.
SUBSTANCE: group of inventions refers to the field of medicine, the chemical-pharmaceutical industry and pharmacy, specifically to a solid dosage form for oral administration, for the treatment of inflammatory diseases of the musculoskeletal system, and to a method for preparing said dosage form. Dosage form contains a non-steroidal anti-inflammatory drug (Z)-3-(2-oxo-2-(4-tolyl)ethylidene)piperazin-2-one, microcrystalline cellulose, stearic acid and/or a pharmaceutically acceptable salt thereof and a lactose monohydrate in the amounts indicated in the claims. Dosage form may additionally comprise hydroxyethylcellulose and polyvinylpyrrolidone. Solid dosage form is in the form of a coated tablet that allows the preparation of an easily swallowed drug. Tablet of the invention can be obtained by wet granulation and direct compression of the components.
EFFECT: tablet of the invention is characterized by a rapid release of the active substance, sufficient strength, storage-stable, meets the requirements of the pharmacopeia.
11 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL ANTI-DIABETIC COMPOSITION BASED ON SUBSTITUTED THIOPHENE CARBOXYLATE AND A METHOD FOR PRODUCTION THEREOF | 2018 |
|
RU2688235C1 |
SOLID DOSAGE FORM OF ANTIDIABETIC DRUG BASED ON N-SUBSTITUTED DERIVATIVE AMRINONE - KINASE INHIBITOR OF GLUCOGEN SYNTHASE | 2016 |
|
RU2663913C1 |
METHOD FOR PREPARING MEDICINAL AGENT CONTAINING VARDENAFIL HYDROCHLORIDE TRIHYDRATE | 2008 |
|
RU2493849C2 |
AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
PHARMACEUTICAL COMPOSITIONS OF MONTELUCAST AND LEVOCETIRISINE | 2013 |
|
RU2677649C2 |
SOLID INDIVIDUAL HIGH 2-ETHYL-6-METHYL-3-PYRIDIN-3-OLE HYDROCHLORIDE DOSAGE FORM AND METHOD FOR PREPARING IT | 2010 |
|
RU2448686C1 |
PHARMACEUTICAL COMPOSITION HAVING ANTIULCER ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2736184C1 |
PHARMACEUTICAL COMPOSITION WITH 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING IT | 2010 |
|
RU2444359C1 |
PHARMACEUTICAL COMPOSITIONS CONTAINING AMINO COMPOUND | 2012 |
|
RU2607480C2 |
PHARMACEUTICAL COMPOSITION FOR CORRECTION OF PSYCHOSOMATIC MANIFESTATIONS | 2009 |
|
RU2384336C1 |
Authors
Dates
2018-06-14—Published
2017-10-04—Filed